Jason Del Vicario
Integrated Diagnostics
IDHC-LSE
PAST TOP PICK
Feb 08, 2023
(A Top Pick Jan 21/22, Down 52%)
Business is operating very well. Boom in profits and revenues during Covid. Now, earnings have gone back to trend, expecting to grow by 15-20% this year. However, Egyptian Pound has been decimated by 50%, and this really hurts when converted to USD. Company's been around for 40 years, not the first macro challenge. Geopolitical risk beyond his control. A 3% conviction rate for him. He's been nibbling at shares around 64 cents.
Unknown company that has good financial metrics (cash flow, return on equity).
High insider ownership.
Attractive valuation with strong dividend.
Low conviction on ownership due to instability of Middle East.
Is run by the founder who owns 40% of shares. Based on Egypt with operations in Jordan and parts of Africa. It trades at 5x earnings and pays a 15% dividend. Has been adding to it. Only a 3% weight in his portfolio given its geopolitical and currency risk. Generates strong returns and is expanding. (Analysts’ price target is $1.48)
Your Watchlist
Add stocks to watchlist to monitor them daily and get important alerts.
Business is operating very well. Boom in profits and revenues during Covid. Now, earnings have gone back to trend, expecting to grow by 15-20% this year. However, Egyptian Pound has been decimated by 50%, and this really hurts when converted to USD. Company's been around for 40 years, not the first macro challenge. Geopolitical risk beyond his control. A 3% conviction rate for him. He's been nibbling at shares around 64 cents.